News

Filter

Current filters:

Theraclone Sciences

PharmAthene pulls out of merger deal with Theraclone

03-12-2013

USA-based biodefense company PharmAthene has decided to terminate its previously-announced all stock…

Mergers & AcquisitionsPharmaceuticalPharmAtheneTheraclone Sciences

PharmAthene and Theraclone agree merger

02-08-2013

USA-based biodefense company PharmAthene (NYSE MKT: PIP) and privately-held monoclonal antibody specialist…

BiotechnologyMergers & AcquisitionsPharmAtheneTheraclone Sciences

Theraclone set to earn up to $632 million in antibodies deal with Pfizer

20-01-2011

Privately held, Seattle-based discovery-stage biotech firm Theraclone Sciences says it has entered into…

Antibiotics and Infectious diseasesLicensingOncologyPfizerPharmaceuticalResearchTheraclone Sciences

COMPANY SPOTLIGHT

Menarini

Back to top